Earnings Reports

Found 67,109 articles

• Nanobiotix Announces Third Quarter 2020 Revenue

  10/23/2020

  NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced its unaudited revenue for the third quarter of 2020.

• Cronos Group Inc. to Hold 2020 Third Quarter Earnings Conference Call on November 5, 2020

  10/23/2020

  Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Third Quarter Earnings Conference Call on Thursday, November 5, 2020 at 8:30 a.m. EST.

• Alpha Pro Tech, Ltd. Announces Date of Release Of Financial Results For Third Quarter 2020

  10/23/2020

  Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced that the Company will release financial results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020, before the market opens.

• Avantor® Announces Preliminary Third Quarter Unaudited Revenues

  10/23/2020

  - Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, provided preliminary unaudited revenue estimates for the third quarter ended September 30, 2020 , in conjunction with proposed debt refinancing tran

• Ocular Therapeutix™ To Report Third Quarter 2020 Financial Results

  10/23/2020

  Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced that it will report third quarter financial results on Thursday, November 5, 2020.

• ADVANZ PHARMA Corp. Limited Announces Release Date for Third Quarter 2020 Results

  10/23/2020

  ADVANZ PHARMA Corp. Limited announced it intends to release its third quarter, 2020 financial results before market open on Friday, November 6, 2020.

• Assertio to Release Third Quarter 2020 Financial Results and Host Webcast on November 6, 2020

  10/23/2020

  Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, today announced that its third quarter 2020 financial results will be released on Friday, November 6, 2020

• BioDelivery Sciences to Report Third Quarter 2020 Financial Results on November 5, 2020

  10/23/2020

  BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its third quarter 2020 financial results before the open of the U.S. financial markets on Thursday, November 5, 2020.

• Beyond Air® Schedules Second Fiscal Quarter 2021 Financial Results Conference Call and WebcastCall scheduled for Wednesday, November 11th at 4:30 pm Eastern Time

  10/23/2020

  Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid tumors and tumor metastases, today announced it will report financial results for its second fiscal quarter ended September 30, 2020

• Invitae to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020

  10/23/2020

  Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its third quarter 2020 financial results on Thursday, November 5, 2020 and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.

• CV Sciences, Inc. to Announce Third Quarter 2020 Results on November 5, 2020

  10/23/2020

  CV Sciences, Inc., a preeminent supplier and manufacturer of hemp cannabidiol products, announced that it will release financial results for the third quarter ended September 30, 2020, after the stock market closes on Thursday, November 5, 2020.

• Matinas BioPharma to Webcast Conference Call Discussing Third Quarter 2020 Financial and Operational Results on November 6, 2020

  10/23/2020

  Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Friday, November 6, 2020 at 8:30 a.m. ET to discuss operational and financial results for the third quarter ended September 30, 2020.

• Amyris To Host Third Quarter 2020 Financial Results Conference Call On November 5

  10/23/2020

   Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the fiscal 2020 third quarter ended September 30, 2020 on Thursday, Nov

• Adaptimmune to Report Q3 Financial Results and Business Update on Thursday, November 5, 2020

  10/22/2020

  Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, will report financial results and provide a business update for Q3 2020, before the U.S. markets open on Thursday, November 5, 2020.

• Alkermes to Host Conference Call to Discuss Third Quarter 2020 Financial Results

  10/22/2020

  Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (12:00 p.m. GMT) on Thursday, Oct. 29, 2020 to discuss the company's third quarter 2020 financial results

• Repligen to Report Third Quarter 2020 Financial Results

  10/22/2020

  Webcast and Conference Call to Be Held Thursday, November 5, 2020 at 8:30 a.m. EST

• Nevro to Report Third Quarter 2020 Financial Results

  10/22/2020

  Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the Company will release its financial results for the third quarter ended September 30, 2020 after the market closes on November 5, 2020.

• Dynavax to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5, 2020

  10/22/2020

  Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, will report third quarter 2020 financial results on Thursday, November 5, 2020, after the U.S. financial markets close.

• Strongbridge Biopharma plc to Host Third Quarter 2020 Financial Results Conference Call on October 29, 2020

  10/22/2020

  Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, announced that it will host a conference call with members of Strongbridge’s management team on Thursday, October 29 at 4:30 p.m. ET to discuss the Company’s third quarter 2020 financial results and to provide a business update.

• ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2020 Operating Results

  10/22/2020

  ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, November 6, 2020 to discuss its third quarter operating results.